Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
7.13
+1.48 (26.19%)
At close: Aug 14, 2026, 4:00 PM EDT
6.98
-0.15 (-2.10%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Valneva SE Employees
Valneva SE had 674 employees as of December 31, 2025. The number of employees decreased by 39 or -5.47% compared to the previous year.
Employees
674
Change (1Y)
-39
Growth (1Y)
-5.47%
Revenue / Employee
$242,287
Profits / Employee
-$267,225
Market Cap
658.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 674 | -39 | -5.47% |
| Dec 31, 2024 | 713 | 37 | 5.47% |
| Dec 31, 2023 | 676 | -43 | -5.98% |
| Dec 31, 2022 | 719 | -43 | -5.64% |
| Dec 31, 2021 | 762 | 262 | 52.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Prime Medicine | 146 |
| MapLight Therapeutics | 133 |
| Artiva Biotherapeutics | 115 |
| Adlai Nortye | 109 |
| OmniAb | 89 |
| Assembly Biosciences | 73 |
| Altimmune | 57 |
| Zura Bio | 40 |
VALN News
- 1 day ago - Valneva Stock (VLN) Soars Over 20% On Lyme Disease Vaccine Hopes - TipRanks
- 1 day ago - Pfizer And Valneva's Lyme Vaccine Clears EMA Review Gate - Nasdaq
- 1 day ago - Pfizer, Valneva's Lyme Disease Vaccine Application Validated By EMA - Nasdaq
- 1 day ago - Pfizer Inc.: Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Finanz Nachrichten
- 1 day ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - GlobeNewsWire
- 1 day ago - Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Wallstreet:Online
- 1 day ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Business Wire
- 2 days ago - Valneva Q2 Earnings Call Highlights - MarketBeat